Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 272

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 2
Chunk 272
---
876 1%$5,033 $4,855 4 %Pre-tax margin (1)(2)3.2 %3.6 %(40)bps2.9 %3.3 %(40)bpsSG&A expense ratio (3)1.7 %1.7 %— bps1.8 %1.9 %(10)bps

(1)See Note 17 to the Consolidated Financial Statements for reconciliation of adjusted revenues and pre-tax adjusted income from operations to Total revenues and Income before income taxes, respectively. 

(2)Pre-tax margin is calculated as pre-tax adjusted income from operations divided by adjusted revenues.

(3)SG&A expense ratio is calculated as segment selling, general and administrative expenses divided by adjusted revenues. See Note 17 to the Consolidated Financial Statements for further details.

43

In this selected financial information, we present adjusted revenues and pre-tax income from operations by our two operating segments, Pharmacy Benefit Services and Specialty and Care Services. 

Selected Financial InformationThree Months EndedSeptember 30,ChangeNine Months EndedSeptember 30,Change(Dollars and adjusted scripts in millions)2025202420252024Total adjusted revenuesPharmacy Benefit Services$34,091 $28,812 18 %$95,787 $81,549 17 %Specialty and Care Services26,300 23,825 10 76,110 66,862 14 Total adjusted revenues$60,391 $52,637 15 %$171,897 $148,411 16 %Pre-tax adjusted income from operationsPharmacy Benefit Services$975 $1,038 (6)%$2,352 $2,379 (1)%Specialty and Care Services928 838 11 2,681 2,476 8 Total pre-tax adjusted income from operations$1,903 $1,876 1 %$5,033 $4,855 4 %Pharmacy claim volume (1)558 531 5 %1,645 1,577 4 %

(1)Non-specialty network prescriptions filled through 90-day programs and home delivery prescriptions are counted as three claims. All other network and specialty prescriptions are counted as one claim.

Three and Nine Months Ended September 30, 2025 versus Three and Nine Months Ended September 30, 2024

Commentary in parentheses